ChoiceStock, a US stock analysis specialist site, gave Medipast an investment attractiveness score of 96 points and a buy recommendation. Medipast's closing price on June 30 was $138.77, undervalued compared to the fair price of $174.00. The stock is considered to have high upside potential as it must exceed $204.62 to be overvalued.
★ Check Medipast's Fair Price and Investment Attractiveness
![[US Stock Hidden Champion] Medipast, Investment Attractiveness 96 Points..."Buy"](https://cphoto.asiae.co.kr/listimglink/1/2020070113081836545_1593576498.png)
Medipast (MED) is a company that manufactures, sells, and distributes weight management and health-related products. The company offers a variety of products under brand names such as OPTAVIA, Optimal Health, and Essential 1, including pretzels, oatmeal and cereal crunch products, beverages, pancakes, puddings, shakes, and soups.
Medipast also has strong dividend appeal. Its dividends per share have increased annually from $0.25 in 2015 to $1.07, $1.44, $2.19, and $3.38. This year's expected dividend yield is around 3%.
★ Check Medipast's Dividend History
ChoiceStock is a US stock analysis service that uses big data and algorithms to discover stocks and provides directly analyzed investment points, fair prices, and trading strategies, gaining great popularity among US stock investors.
ChoiceStock's main US stock services include ▲stock recommendations ▲recommended portfolios ▲investment attractiveness scores and fair prices for all stocks ▲investment attractiveness rankings for all stocks ▲lists of dividend stocks, growth stocks, and other stock genealogies ▲10-year financial charts and investment indicators ▲dividend information.
★ Apply for a Free Trial of ChoiceStock US
Recent Hot Issue Stocks
Samsung Electronics, Medytox, Dreamtech, Celltrion, Hyundai Livart
※ This content is independent of Asia Economy's editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
